我們公司抗體的選擇對(duì)策詳解
<p class="MsoNormal"><span style="color: rgb(255, 102, 0);"><strong><span style="font-family: 宋體; font-size: 9pt;">★ 分析您的試驗(yàn)應(yīng)用的類(lèi)型 </span></strong></span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><font face="宋體">一般抗體說(shuō)明書(shū)都列出該抗體經(jīng)試驗(yàn)驗(yàn)證過(guò)適用于何種分析類(lèi)型,如:可以應(yīng)用于</font>WB IHC ICC ELASA<font face="宋體">分析等,如果抗體說(shuō)明書(shū)沒(méi)有提及的應(yīng)用類(lèi)型,并不意味著該抗體不適用于此種分析應(yīng)用類(lèi)型;</font></span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;">而僅是說(shuō)明尚未經(jīng)過(guò)此種分析試驗(yàn)驗(yàn)證,如果抗體不適用某些分析試驗(yàn),則會(huì)在抗體說(shuō)明書(shū)上標(biāo)注出來(lái)不適于某分析試驗(yàn)。</span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color: rgb(255, 102, 0);"><strong><span style="font-family: 宋體; font-size: 9pt;">★ 雙重染色抗體的選擇</span></strong></span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;">用未偶聯(lián)一抗進(jìn)行細(xì)胞培養(yǎng)物或組織切片的雙重免疫染色要求一抗來(lái)源于不同物種并且二抗分別識(shí)別其中之一,二抗說(shuō)明書(shū)應(yīng)描述其與其它物種來(lái)源的免疫球蛋有否有交叉吸附。</span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color: rgb(255, 102, 0);"><strong><span style="font-family: 宋體; font-size: 9pt;">★ 樣本的物種</span></strong></span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;">應(yīng)選擇物種相同或有交叉反應(yīng)的抗體,抗體可能與不同物種的同種靶蛋白有交叉反應(yīng),因其氨基酸序列同源性較高,如果樣本的種類(lèi)未列入抗體說(shuō)明書(shū)上的交叉反應(yīng)種屬表中;</span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><font face="宋體">并不意味著該抗體不適用于檢測(cè)該物種的蛋白,而只是表示該物種尚未用此抗體檢測(cè)驗(yàn)證過(guò),應(yīng)通過(guò)序列比對(duì)的方法來(lái)預(yù)測(cè)交叉反應(yīng),可應(yīng)用</font>Expasy <font face="宋體">和 </font><font face="Calibri">NCBI BLAST</font><font face="宋體">來(lái)進(jìn)行不同物種蛋白同源性比對(duì)。</font></span><span style="mso-spacerun:'yes';font-family:宋體;mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:'Times New Roman';font-size:9.0000pt;mso-font-kerning:1.0000pt;"><o:p></o:p></span></p>